Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3802319 | 0.81 | MAOA (0.58) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL7097279 | 0.73 | KDM4E (0.69) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL13502296 | 0.73 | KDM4E (0.65) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL2102718 | 0.70 | ALDH1A1 (0.69) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL869986 | 0.69 | GPR3 (0.40) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL18045173 | 0.69 | ALDH1A1 (0.77) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL85996 | 0.67 | MAOB (0.62) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL3661536 | 0.67 | NPC1 (0.83) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL30120715 | 0.67 | KDM4E (0.83) | KDM4EALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL13356708 | 0.67 | NPC1 (0.57) | KDM4EALDH1A1MAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9062064-B2 | Heterocyclic compounds and the use thereof in electronic and optoelectronic components | NOVALED AG (DE) | 2015-06-23 | — | — | US | claimed |
| CN-102317406-A | Heterocyclic compounds and their use in electronic and optoelectronic components | NOVALED AG | 2012-01-11 | — | — | CN | claimed |
| US-20110309307-A1 | Heterocyclic Compounds and the Use Thereof in Electronic and Optoelectronic Components | NOVALED AG (DE) | 2011-12-22 | — | — | US | claimed |
| WO-2010075836-A2 | HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN ELECTRONIC AND OPTOELECTRONIC COMPONENTS | NOVALED AG (DE) | 2010-07-08 | — | — | WO | claimed |
| US-9062064-B2 | Heterocyclic compounds and the use thereof in electronic and optoelectronic components | NOVALED AG (DE) | 2015-06-23 | — | — | US | disclosed |
| US-8637858-B2 | Tandem white OLED | NOVALED AG (DE) | 2014-01-28 | — | — | US | disclosed |
| US-20120074392-A1 | Tandem White OLED | NOVALED AG (DE) | 2012-03-29 | — | — | US | disclosed |
| CN-102317406-A | Heterocyclic compounds and their use in electronic and optoelectronic components | NOVALED AG | 2012-01-11 | — | — | CN | disclosed |
| US-20110309307-A1 | Heterocyclic Compounds and the Use Thereof in Electronic and Optoelectronic Components | NOVALED AG (DE) | 2011-12-22 | — | — | US | disclosed |
| WO-2010075836-A2 | HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN ELECTRONIC AND OPTOELECTRONIC COMPONENTS | NOVALED AG (DE) | 2010-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110309307-A1 | Heterocyclic Compounds and the Use Thereof in Electronic and Optoelectronic Components | TRPA1, SLC18A3, CYBA | KDM4E 4430/4885ALDH1A1 574/4885MAPT 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.